SUMMIT, N.J.--(BUSINESS WIRE) June 06, 2019 -- Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application for ozanimod for the treatment of people with... (Source: Drugs.com - New Drug Applications)


Read full article on medworm.com


Powered by Preisvergleich



 
 

Follow Us on Twitter

Follow Us On Twitter - Image